MedTrace Logo

Efficacy of Long Term Plavix Therapy Post Angioplasty

NCT02327741 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1010

Last updated 2020-04-29

Study results available
· View outcomes & findings →

Summary

1010 patients post stenting were enrolled to receive Plavix more than 12 months and less than that and rate of bleeding, complication and major cardiovascular adverse events ( MACE) were compared to evaluate safety and feasibility of long term Plavix therapy post stenting.

Conditions

  • Percutaneous Coronary Intervention

Interventions

DRUG

plavix

taking plavix more than 12 months

DRUG

plavix

taking plavix less than 12 months

Sponsors & Collaborators

  • Baqiyatallah Medical Sciences University

    collaborator OTHER

  • Shiraz University of Medical Sciences

    lead OTHER

Principal Investigators

  • javad kojuri, M.D. M.S. · shiraz university of medcal sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-09-30
Completion
2014-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02327741 on ClinicalTrials.gov